Physician profile

Amit Karmur

Vascular Surgery · Wildomar, CA

NPI 1700134830

$11,345.59

in general payments reported to CMS, 2019-2025

29 companies · $966 in 2025

The $966 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,826.90
Travel and Lodging$2,184.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Cardiovascular Systems INC. $1,986.98 2021-2022
Medtronic, INC. $1,729.10 2021-2025 Endurant Iis, Ellipsys Vascular Access System, Venaseal
Silk Road Medical, INC. $1,327.21 2021-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Penumbra, INC. $1,192.83 2023 Indigo System
Angiodynamics, INC. $929.44 2022-2024 Auryon Laser System 100-120 Vac
Medtronic Vascular, INC. $744.81 2019-2020
Inari Medical, INC. $431.32 2022-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
W. L. Gore & Associates, INC. $425.66 2021
Endologix LLC $347.49 2025 Torus Stent Graft System, Endocross Device
Becton, Dickinson and Company $253.16 2024 Lutonix Drug Coated Balloon, Crosser Iq, Halo One Thin-Walled Guiding Sheath
Veryan Medical Incorporated $234.02 2022-2023 Biomimics 3d Vascular Stent System
Boston Scientific Corporation $220.49 2024-2025 Varithena Administration Pack, Enroute Transcarotid Stent, Ranger
Abbott Laboratories $207.81 2023-2024 Diamondback Peripheral, Esprit, Jeti All In One Non-Sterile Kit
Cordis US Corp. $188.99 2023-2025 Mynx Venous Vcd, S.M.A.R.T., Mynx Control
Cook Medical LLC $166.13 2021-2024 Zenith, Zenith Spiral-Z
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Lemaitre Vascular, INC. $139.34 2021-2024 Trivex System
Cagent Vascular INC $127.02 2023-2024 Serrantor
Abiomed $117.69 2025
Kerecis Limited $92.40 2025 Kerecis Surgiclose, Kerecis Graftguide
Innocoll Pharmaceuticals Limited $88.23 2022
Argon Medical Devices, INC. $83.36 2023-2024 Cleaner, Clot Management
Stryker Corporation $78.36 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt
Bard Peripheral Vascular, INC. $73.58 2022-2025 Lifestream, Lutonix Drug Coated Balloon
Ethicon US, LLC $53.37 2024 Echelon Flex, Ethicon, Mega Soft
Reflow Medical INC $37.14 2025
Lilly USA, LLC $19.61 2024 Zepbound, Jardiance
Shockwave Medical, INC $19.52 2022
Integra Lifesciences Corporation $17.88 2024 Integra, Primatrix, Integra Dermal Regeneration Template
Acera Surgical, INC. $12.65 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amit Karmur

$11,345.59

in general payments reported 2019-2025

Years
2019-2025
Top company
Cardiovascular Systems INC.
Context
The $966 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/4225488/amit-karmur

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.